- Home
- CMMB vs IBO Comparison
CMMB vs IBO Comparison
Compare CMMB & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- IBO
- Stock Information
- Founded
- CMMB 2004
- IBO 2018
- Country
- CMMB Israel
- IBO United States
- Employees
- CMMB N/A
- IBO N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- IBO
- Sector
- CMMB Health Care
- IBO
- Exchange
- CMMB Nasdaq
- IBO NYSE
- Market Cap
- CMMB 23.6M
- IBO 22.1M
- IPO Year
- CMMB N/A
- IBO 2024
- Fundamental
- Price
- CMMB $1.16
- IBO $0.57
- Analyst Decision
- CMMB Strong Buy
- IBO
- Analyst Count
- CMMB 2
- IBO 0
- Target Price
- CMMB $9.00
- IBO N/A
- AVG Volume (30 Days)
- CMMB 153.9K
- IBO 8.8M
- Earning Date
- CMMB 03-03-2025
- IBO 05-23-2025
- Dividend Yield
- CMMB N/A
- IBO N/A
- EPS Growth
- CMMB N/A
- IBO N/A
- EPS
- CMMB N/A
- IBO N/A
- Revenue
- CMMB N/A
- IBO N/A
- Revenue This Year
- CMMB N/A
- IBO N/A
- Revenue Next Year
- CMMB N/A
- IBO N/A
- P/E Ratio
- CMMB N/A
- IBO N/A
- Revenue Growth
- CMMB N/A
- IBO N/A
- 52 Week Low
- CMMB $0.58
- IBO $0.51
- 52 Week High
- CMMB $2.55
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- CMMB 31.89
- IBO N/A
- Support Level
- CMMB $0.92
- IBO N/A
- Resistance Level
- CMMB $1.35
- IBO N/A
- Average True Range (ATR)
- CMMB 0.12
- IBO 0.00
- MACD
- CMMB -0.01
- IBO 0.00
- Stochastic Oscillator
- CMMB 24.79
- IBO 0.00
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.